μ- and δ-Opioid receptor antagonists precipitate similar withdrawal phenomena in butorphanol and morphine dependence

Neurochemical Research

Volumn 21, Issue 1, 1996, Pages 63-71

  Feng, Y Z ^a   Zhang, T ^a   Tokuyama, S ^a   Zhu, H ^a   Rockhold, R W ^a   Ho, I K ^a  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

Butorphanol; CTOP; glutamate; locus coeruleus; morphine; naltrindole

Indexed keywords

ASPARTIC ACID; BUTORPHANOL; DELTA OPIATE RECEPTOR; DELTA OPIATE RECEPTOR ANTAGONIST; DEXTRO PHENYLALANYLCYSTEINYLTYROSYL DEXTRO TRYPTOPHYLORNITHYLTHREONYLPENICILLAMINYLTHREONINAMIDE 2,7 DISULFIDE; GLUTAMIC ACID; MORPHINE; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR ANTAGONIST; NALTRINDOLE;

AMINO ACID BRAIN LEVEL; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; DRUG WITHDRAWAL; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; LOCUS CERULEUS; MALE; MICRODIALYSIS; NONHUMAN; OPIATE ADDICTION; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING;

ANIMALS; BUTORPHANOL; DRUG EVALUATION, PRECLINICAL; INJECTIONS, INTRAVENTRICULAR; LOCUS COERULEUS; MALE; MORPHINE; MORPHINE DEPENDENCE; NALTREXONE; NARCOTIC ANTAGONISTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, MU; SOMATOSTATIN; SUBSTANCE WITHDRAWAL SYNDROME;

ANIMALIA;

EID: 0029931036     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02527673     Document Type: Article

References (39)

1. Abdelhamid, E. E., Sultana, M., Portoghese, P. S., and Takemori, A. E. 1991. Selective blockage of delta opioid receptors prevents the development of morphine tolerance and dependence in mice. J. Pharmacol. Exp. Ther. 258:299-301.
2. Heel, R. C., Brogden, R. N., Speight, T. M. and Avery, G. S. 1978. Butorphanol: A review of its pharmacological properties and therapeutic efficacy. Drugs 16:473-505.
3. Horan, P., and Ho, I. K. 1989. Comparative pharmacological and biochemical studies between butorphanol and morphine. Pharmacol. Biochem. Behav. 34:847-854.
4. Horan, P., and Ho, I. K. 1991. The physical dependence liability of butorphanol: a comparative study with morphine. Eur. J. Pharmacol. 203:387-391.
5. Jaw, S. P., Hoskins, B., and Ho, I. K. 1993. Involvement of δ-opioid receptors in physical dependence on butorphanol. Eur. J. Pharmacol. 240:67-72.
6. Jaw, S. P., Hoskins, B., and Ho, I. K. 1993. Opioid antagonists and butorphanol dependence. Pharmacol. Biochem. Behav. 44: 497-500.
7. Martin, W. R., Eades, C. G., Thompson, J. A., Huppler, R. E., and Gilbert, P. E. 1976. The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog. J. Pharmacol. Exp. Ther. 197:517-532.
8. 2 opioid receptors in the development of morphine dependence in mice. J. Pharmacol. Exp. Ther. 264:1141-1145.
9. Monkovic, I., Conway, T. T., Wong, H., Perron, Y. G., Pachter, I. J., and Beieau, B. 1973. Total synthesis and pharmacological activities on N-substitutcd 3,14-dihydroxymorphinans. J. Am. Chem. Soc. 95:7910-7911.
10. Oh, K. W., Makimura, M., Jaw, S. P., Hoskins, B., and Ho, I. K. 1992. Effects of β-funaltrexamine on butorphanol dependence. Pharmacol. Biochem. Behav. 42:29-34.
11. Picker, M. J., Negus, S. S., and Craft, R. M. 1990. Butorphanol's efficacy at mu and kappa opioid receptors: inferences based on the schedule-controlled behavior of nontolerant and morphine-tolerant rats and on the responding of rats under a drug discrimination procedure. Pharmacol. Biochem. Behav. 36:563-568.
12. Pircio, A. W., Gylys, J. A., Cavanagh, R. L., Buynishi, J. P., and Bierwagen, M. E. 1976. The pharmacology of butorphanol, a 3,14-dihydroxymorphinan narcotic antagonist analgesic. Arch. Int. Pharmacodyn. 220:231-257.
13. 2 (CTOP) in mice. Eur. J. Pharmacol. 150:355-360.
14. Aghajanian, G. K. 1978. Tolerance of locus neurons to morphine and suppression of withdrawal response by clonidine. Nature 276: 186-188.
15. Feng, Y. Z., Zhang, T., Rockhold, R. W., and Ho, I. K. 1995. Increased locus coeruleus glutamate levels are associated with naloxone-precipitated withdrawal from butorphanol in the rat. Neurochem. Res. 20:745-751.
16. Redmond, D. E. Jr., and Krystal, J. H. 1984. Multiple mechanisms of withdrawal from opioid drugs. Annu. Rev. Neurosci. 7:443-478.
17. Foote, S. L., Bloom, F. E., and Aston-Jones, G. 1983. Nucleus locus coeruleus: new evidence of anatomical and physiological specificity. Physiol. Rev. 63:844-914.
18. Rasmussen, K., and Aghajanian, G. K. 1989. Withdrawal-induced activation of locus coeruleus neurons in opiate-dependent rats: attenuation by lesions of the nucleus paragigantocellularis. Brain Res. 505:346-350.
19. Maldonado, R., Stinus, L., Gold, L. H., and Koob, G. F. 1992. Role of different brain structures in the expression of the physical morphine withdrawal syndrome. J. Pharmacol. Exp. Ther. 261: 669-677.
20. Aghajanian, G. K., Kogan, J. H., and Moghaddam, B. 1994. Opiate withdrawal increases glutamate and aspartate efflux in the locus coeruleus: an in vivo microdialysis study. Brain Res. 636:126-130.
21. Hong, M., Milne, B., and Jhamandas, K. 1993. Evidence for the involvement of excitatory amino acid pathways in the development of precipitated withdrawal from acute and chronic morphine: an in vivo voltammetric study in the rat locus coeruleus. Brain Res. 623:131-141.
22. Zhang, T., Feng, Y. Z., Rockhold, R. W., and Ho, I. K. 1994. Naloxone-precipitated morphine withdrawal increases pontine glutamate levels in the rat. Life Sci. 55:PL25-31.
23. Rasmussen, K., Beitner-Jonson, D. B., Krystal, J. H., Aghajanian, G. K. and Nestler, E. J. 1990. Opiate withdrawal and the rat locus coeruleus: behavioral, electrophysiological, and biochemical correlates. J. Neurosci. 10:2308-2317.
24. Rasmussen, K., Krystal, J. H., and Aghajanian, G. K. 1991. Excitatory amino acids and morphine withdrawal: differential effects of central and peripheral kynurenic acid administration. Psychopharmacology. 105:508-512.
25. Tanganelli, S., Antonelli, T., Morari, M., Bianchi, C., and Beani, L. 1991. Glutamate antagonists prevent morphine withdrawal in mice and guinea pigs. Neurosci. Lett. 122:270-272.
26. Trujillo, K. A., and Akil, H. 1991. Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science 251:85-87.
27. Robers, H., Hyes, A. G., Birch, P. J., Traynor, J. R. and Lawrence, A. J. 1990. The selectivity of the opioid antagonist, naltrindole, for δ-opioid receptors. J. Pharm. Pharmacol. 42:358-359.
28. Paxinos, G., and Watson, C. 1986. The Rat Brain in Stereotaxic Coordinates, 2nd edition, Academic Press, Orlando, Florida.
29. Feng, Y. Z., Narita, M., Tseng, Y. T., Hoskins, B., and Ho, I. K. 1994. Crosstolerance between butorphanol and morphine in rats. Pharmacol. Biochem. Behavior. 49:657-661.
30. Ellison, D. W., Beal, M. F., and Martin, J. B. 1987. Amino acid neurotransmitters in postmortem human brain analyzed by high performance liquid chromatography with electrochemical detection. J. Neurosci. Methods. 19:305-315.
31. McCarthy, P. S., Metacalf, G., and Howe, S. J. 1982. Continuous infusion in rats as a method of assessing morphine-like physical dependence for opiates. Pharmacol. Biochem. Behav. 16:725-729.
32. McCarthy, P. S., and Howlett, G. J. 1984. Physical dependence induced by opiate partial agonists in the rat. Neuropeptides 5:11-14.
33. Brown, G. R. 1985. Stadol dependence: Another case. J. Am. Med. Assoc. 254:910.
34. Evans, W. S., Bowen, J. N., Giordano, F. L., and Clark, B. 1985. A case of stadol dependence. J. Am. Med. Assoc. 253:2191-2192.
35. Hoover, R. C., and Williams, R. B. 1985. Survey of butorphanol and nalbuphine diversion in U.S. hospitals. Am. J. Hosp. Pharm. 42:1111-1113.
36. Jasinski, D. R., Preston, K. L. and Testa, M. 1988. Abuse potential evaluation of transnasally given butorphanol in humans. The Pharmacologist 30:A196.
37. Smith, S. G., and Davis, W. M. 1984. Nonmedical use of butorphanol and diphenhydramine. J. Am. Med. Assoc. 252:1010.
38. Rasmussen, K. 1991. Afferent effects on locus coeruleus in opiate withdrawal, In Progress in Brain Research (Barnes C. D., and Pompeiano O., eds), 88:207-216. Elsevier Science Publishers B. V., Amsterdam, Netherlands.
39. Feng, Y., Zhang, T., Rockhold, R. W., and Ho, I. K. 1994. Opioid receptor subtypes modulate pontine excitatory amino acid (EAA) levels differently in butorphanol and morphine dependence. Soc. Neurosci. Abst. 20:1167.